The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 1997-12, Vol.11 (12), p.2039-2044
Hauptverfasser:	KOLLER, C. A, KANTARJIAN, H. M, THOMAS, D, O'BRIEN, S, RIOS, M. B, KORNBLAU, S, MURPHY, S, KEATING, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Biological and medical sciences Chemotherapy Medical sciences Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	2044
container_issue	12
container_start_page	2039
container_title	Leukemia
container_volume	11
creator	KOLLER, C. A KANTARJIAN, H. M THOMAS, D O'BRIEN, S RIOS, M. B KORNBLAU, S MURPHY, S KEATING, M
description
doi_str_mv	10.1038/sj.leu.2400861
format	Article
fullrecord	<record><control><sourceid>pascalfrancis_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1038_sj_leu_2400861</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2117691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2871-ab5cb8deb785230b802128448f418f41ceee6de4c093dabd45239198b6130a453</originalsourceid><addsrcrecordid>eNo9kDFPwzAQhS0EEqGwMntgTfA5juOMVYGCVAmGwhrZzoU4JE1kp0j996RqxXC64d337ukRcg8sAZaqx9AmHe4TLhhTEi5IBCKXcZZlcEkiplQey4KLa3ITQsvYUZQR-dg2SJvDiD5efS2fqMdv1-OOun70wy8GOuwnO_RI3W7WOj0GrKi2-wlpd-jHZjCdDpOzdH79g73Tt-Sq1l3Au_NekM-X5-3qNd68r99Wy01sucoh1iazRlVocpXxlBnFOHAlhKoFHMcioqxQWFaklTaVmK8KKJSRkDItsnRBkpOv9UMIHuty9K7X_lACK499lKEt51DluY8ZeDgBow5Wd7XXO-vCP8UBcllA-gex7GGL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia</title><source>Nature</source><source>EZB-FREE-00999 freely available EZB journals</source><source>SpringerLink Journals - AutoHoldings</source><creator>KOLLER, C. A ; KANTARJIAN, H. M ; THOMAS, D ; O'BRIEN, S ; RIOS, M. B ; KORNBLAU, S ; MURPHY, S ; KEATING, M</creator><creatorcontrib>KOLLER, C. A ; KANTARJIAN, H. M ; THOMAS, D ; O'BRIEN, S ; RIOS, M. B ; KORNBLAU, S ; MURPHY, S ; KEATING, M</creatorcontrib><identifier>ISSN: 0887-6924</identifier><identifier>EISSN: 1476-5551</identifier><identifier>DOI: 10.1038/sj.leu.2400861</identifier><identifier>CODEN: LEUKED</identifier><language>eng</language><publisher>London: Nature Publishing</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Chemotherapy ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Leukemia, 1997-12, Vol.11 (12), p.2039-2044</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2871-ab5cb8deb785230b802128448f418f41ceee6de4c093dabd45239198b6130a453</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,777,781,786,787,23911,23912,25121,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2117691$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>KOLLER, C. A</creatorcontrib><creatorcontrib>KANTARJIAN, H. M</creatorcontrib><creatorcontrib>THOMAS, D</creatorcontrib><creatorcontrib>O'BRIEN, S</creatorcontrib><creatorcontrib>RIOS, M. B</creatorcontrib><creatorcontrib>KORNBLAU, S</creatorcontrib><creatorcontrib>MURPHY, S</creatorcontrib><creatorcontrib>KEATING, M</creatorcontrib><title>The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia</title><title>Leukemia</title><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>0887-6924</issn><issn>1476-5551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNo9kDFPwzAQhS0EEqGwMntgTfA5juOMVYGCVAmGwhrZzoU4JE1kp0j996RqxXC64d337ukRcg8sAZaqx9AmHe4TLhhTEi5IBCKXcZZlcEkiplQey4KLa3ITQsvYUZQR-dg2SJvDiD5efS2fqMdv1-OOun70wy8GOuwnO_RI3W7WOj0GrKi2-wlpd-jHZjCdDpOzdH79g73Tt-Sq1l3Au_NekM-X5-3qNd68r99Wy01sucoh1iazRlVocpXxlBnFOHAlhKoFHMcioqxQWFaklTaVmK8KKJSRkDItsnRBkpOv9UMIHuty9K7X_lACK499lKEt51DluY8ZeDgBow5Wd7XXO-vCP8UBcllA-gex7GGL</recordid><startdate>19971201</startdate><enddate>19971201</enddate><creator>KOLLER, C. A</creator><creator>KANTARJIAN, H. M</creator><creator>THOMAS, D</creator><creator>O'BRIEN, S</creator><creator>RIOS, M. B</creator><creator>KORNBLAU, S</creator><creator>MURPHY, S</creator><creator>KEATING, M</creator><general>Nature Publishing</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19971201</creationdate><title>The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia</title><author>KOLLER, C. A ; KANTARJIAN, H. M ; THOMAS, D ; O'BRIEN, S ; RIOS, M. B ; KORNBLAU, S ; MURPHY, S ; KEATING, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2871-ab5cb8deb785230b802128448f418f41ceee6de4c093dabd45239198b6130a453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KOLLER, C. A</creatorcontrib><creatorcontrib>KANTARJIAN, H. M</creatorcontrib><creatorcontrib>THOMAS, D</creatorcontrib><creatorcontrib>O'BRIEN, S</creatorcontrib><creatorcontrib>RIOS, M. B</creatorcontrib><creatorcontrib>KORNBLAU, S</creatorcontrib><creatorcontrib>MURPHY, S</creatorcontrib><creatorcontrib>KEATING, M</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><jtitle>Leukemia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KOLLER, C. A</au><au>KANTARJIAN, H. M</au><au>THOMAS, D</au><au>O'BRIEN, S</au><au>RIOS, M. B</au><au>KORNBLAU, S</au><au>MURPHY, S</au><au>KEATING, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia</atitle><jtitle>Leukemia</jtitle><date>1997-12-01</date><risdate>1997</risdate><volume>11</volume><issue>12</issue><spage>2039</spage><epage>2044</epage><pages>2039-2044</pages><issn>0887-6924</issn><eissn>1476-5551</eissn><coden>LEUKED</coden><cop>London</cop><pub>Nature Publishing</pub><doi>10.1038/sj.leu.2400861</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0887-6924
ispartof	Leukemia, 1997-12, Vol.11 (12), p.2039-2044
issn	0887-6924 1476-5551
language	eng
recordid	cdi_crossref_primary_10_1038_sj_leu_2400861
source	Nature; EZB-FREE-00999 freely available EZB journals; SpringerLink Journals - AutoHoldings
subjects	Antineoplastic agents Biological and medical sciences Chemotherapy Medical sciences Pharmacology. Drug treatments
title	The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T23%3A56%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20hyper-CVAD%20regimen%20improves%20outcome%20in%20relapsed%20acute%20lymphoblastic%20leukemia&rft.jtitle=Leukemia&rft.au=KOLLER,%20C.%20A&rft.date=1997-12-01&rft.volume=11&rft.issue=12&rft.spage=2039&rft.epage=2044&rft.pages=2039-2044&rft.issn=0887-6924&rft.eissn=1476-5551&rft.coden=LEUKED&rft_id=info:doi/10.1038/sj.leu.2400861&rft_dat=%3Cpascalfrancis_cross%3E2117691%3C/pascalfrancis_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true